Rajesh Shinghal, MD
Urology · Fremont
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 15
- 3 carriers
- Offices
- 9
Offices
9 locations · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Looking this up.
Hospitals listed: El Camino Health · Mills-Peninsula Medical Center · Washington Hospital. That is not proof they admit you there this week.
Plans that list them
15 plans · 3 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Shinghal’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
15 of 15 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Sutter Advantage +More (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A63122 · Current
Licensed to practise in California · since 1997 · expires 2028-09-30 · Stanford University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
3 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- El Camino HealthMountain View, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of El Camino Health, which runs 2 hospitalsPatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.291, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.393, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0, Oct 2024 – Sep 2025
- Peninsula Medical CenterBurlingame, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 78% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.139, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.242, Oct 2024 – Sep 2025
- Washington HospitalFremont, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of Washington Hospital Healthcare SystemPatients rate it 3 of 5 · 71% would definitely recommend itOverall rating: 2 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.188, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.164, Oct 2024 – Sep 2025
See every measure and the patient survey for El Camino Health
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.291 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.393 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.96 (0.12 to 1.79) · 2,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.76 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.38 (125.03 to 209.73) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 185 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 814 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13 · 842 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 361 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 4,633 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.34) · 11,474 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.1 to 0.45) · 11,626 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.14 (1.39 to 4.9) · 2,814 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2 (0.61 to 3.39) · 1,327 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.8 to 3.43) · 2,641 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.39 (4.18 to 14.6) · 1,287 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.57 (3.47 to 9.68) · 1,308 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.14 (0.71 to 3.57) · 827 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.6 (0.05 to 1.15) · 9,460 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.5 · 122 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.993 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.706 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.376 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 218 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.5 · 962 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 3.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -17 · 922 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 18.6 · 860 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.7 · 827 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.1 (4.5 to 8.2) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.4 (10.6 to 16.5) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.7 · 237 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (10 to 16.1) · 1,639 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.8 to 1.1) · 1,619 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,535 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Peninsula Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.139 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.242 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.21 (0.27 to 2.15) · 1,258 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.81 (0.51 to 1.1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 155.44 (112.67 to 198.21) · 90 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.5 · 32 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 82 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10 · 188 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9 · 473 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.8 · 342 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.4 · 485 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.9 · 3,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.4) · 6,904 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.21 (0.02 to 0.4) · 7,052 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.41 (1.43 to 5.39) · 1,695 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.72 (0.17 to 3.28) · 665 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,545 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.1 (1.3 to 12.9) · 670 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.96 (2.63 to 9.29) · 653 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.61 (0.15 to 3.08) · 418 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.14 (0 to 0.78) · 5,539 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.7 · 192 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.215 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.263 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.74 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.3 · 300 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19 · 702 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 1.2 · 207 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -13.6 · 531 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 24.3 · 343 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.1 · 449 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.5 (2.8 to 7) · 85 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 9.6 (6.7 to 13.7) · 85 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.7 · 189 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11 · 45 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.6 · 117 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13 (9.7 to 17.2) · 584 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 764 cases | No different | Jan 2024 – Dec 2024 |
What patients said (523 patients answered, 27% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 76% |
| Nurses "always" communicated well | 81% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 75% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 54% |
| "YES", patients would definitely recommend the hospital | 78% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
See every measure and the patient survey for Washington Hospital
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 1 better, 6 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.188 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.164 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.88 (0 to 1.88) · 1,112 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.92 (0.59 to 1.24) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 192.95 (139.54 to 246.36) · 48 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2 · 27 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.4 · 164 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.1 · 199 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 463 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.6 · 661 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.3 · 174 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.7 · 2,550 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.15 (0 to 0.35) · 6,970 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.21 (0.02 to 0.4) · 7,108 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.82 (1.73 to 5.91) · 1,370 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.52 (0 to 3.17) · 589 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.75 (0.25 to 3.25) · 1,315 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 13.19 (5.83 to 20.56) · 600 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.91 (1.04 to 8.78) · 550 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.66 (0.17 to 3.14) · 198 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.14 (0 to 0.78) · 6,079 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.7 · 114 cases | None | Apr 2023 – Mar 2025 |
| MRSA BacteremiaInfections | 0 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.367 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.8 · 186 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.9 · 480 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 33.9 · 186 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 26.5 · 553 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 36.8 · 648 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.5 · 590 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.7 (3.2 to 6.9) · 169 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 11.4 (8.5 to 14.9) · 169 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 130 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.1 · 41 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 202 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.7 (10.2 to 18.5) · 78 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.1) · 974 cases | No different | Jan 2024 – Dec 2024 |
What patients said (812 patients answered, 19% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 76% |
| Nurses "always" communicated well | 77% |
| Doctors "always" communicated well | 77% |
| Staff "always" explained | 56% |
| Yes, staff "did" give patients this information | 84% |
| Yes, staff "did" give patients information about help after discharge | 84% |
| Doctors "always" explained things so they could understand | 70% |
| Doctors "always" listened carefully | 76% |
| Doctors "always" treated them with courtesy and respect | 84% |
| Patients who gave a rating of "9" or "10" (high) | 71% |
| Staff "always" explained new medications | 70% |
| Nurses "always" explained things so they could understand | 72% |
| Nurses "always" listened carefully | 74% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 46% |
| "YES", patients would definitely recommend the hospital | 71% |
| Staff "always" explained possible side effects | 42% |
| Yes, staff "did" give patients information about possible symptoms | 84% |
Original Medicare doctor bills
$273,252
Medicare paid this office $273,252 for 673 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 499 | $83,011 | $114 |
| Diagnostic exam of bladder and urethra using an endoscope | 92 | $24,565 | $246 |
| New patient visit (45+ min) | 174 | $23,794 | $137 |
| Crushing of stone of ureter with insertion of stent using an endoscope | 30 | $11,732 | $356 |
| Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope | 27 | $9,004 | $322 |
See all 20 services
| Return visit (30+ min) | 499 | $83,011 | $114 |
| Diagnostic exam of bladder and urethra using an endoscope | 92 | $24,565 | $246 |
| New patient visit (45+ min) | 174 | $23,794 | $137 |
| Crushing of stone of ureter with insertion of stent using an endoscope | 30 | $11,732 | $356 |
| Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope | 27 | $9,004 | $322 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 470 | $8,793 | $14 |
| Short return visit (20+ min) | 83 | $8,039 | $80 |
| Ultrasound measurement of bladder capacity after voiding | 415 | $6,511 | $12 |
| Ultrasound scan of pelvic region through rectum | 42 | $5,868 | $133 |
| Biopsy of prostate gland | 24 | $5,785 | $241 |
| Long return visit (40+ min) | 30 | $5,772 | $170 |
| Other ultrasound procedure | 19 | $4,670 | $246 |
| Hospital discharge day management, more than 30 minutes | 11 | $1,150 | $105 |
| Imaging of urinary tract following injection of a contrast agent | 37 | $850 | $22 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 11 | $745 | $37 |
| Electronic assessment of bladder emptying | 44 | $476 | $10 |
| Automated urinalysis test | 165 | $431 | $2 |
| Injection of drug or substance under skin or into muscle | 18 | $301 | $14 |
| Manual urinalysis test with examination using microscope, automated | 31 | $100 | $3 |
| Injection, garamycin, gentamicin, up to 80 mg | 27 | $58 | None |
Procedures Medicare counted
| Prostate resection | 14 | More than 67% of doctors who do this |
| Removal of skin lesions | 1-10 | None |
| Removal of tissue | 1-10 | None |
Who their Medicare patients are
673 Original Medicare patients in 2024. Average age 76 · Under 65 2% · 85 and older 15% · Women 19% · Also on Medicaid 12% · Health risk score 1.11. At or below the middle of the specialty; the typical urology clinician is at 1.36.
Conditions among them: High blood pressure 72% · Coronary heart disease 33% · Diabetes 28% · Chronic kidney disease 25% · Cancer 22% · Atrial fibrillation 20% · Depression 13% · Heart failure 11% · COPD 7% · Dementia 6% · Stroke 4%.
The office billed $1,315,149, Medicare allowed $360,069 and paid $273,252; for 7,014 services of 95 kinds; $17,609 of it was for drugs given in the office and $255,644 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 673 | 7,014 | 76 | 1.11 | $1,315,149 | $273,252 |
| 2023 | 689 | 10,355 | 76 | 1.06 | $1,311,324 | $283,214 |
| 2022 | 659 | 8,729 | 76 | 1.04 | $1,264,070 | $298,580 |
| 2021 | 641 | 6,408 | 76 | 1.03 | $1,311,083 | $300,663 |
| 2020 | 617 | 3,304 | 76 | 1.23 | $1,241,924 | $279,428 |
| 2019 | 641 | 5,556 | 75 | 1.25 | $1,529,074 | $322,774 |
| 2018 | 513 | 3,907 | 76 | 1.21 | $1,276,164 | $252,132 |
| 2017 | 467 | 3,286 | 75 | 1.26 | $959,795 | $209,679 |
| 2016 | 406 | 1,805 | 75 | 1.27 | $702,388 | $151,828 |
| 2015 | 355 | 1,687 | 74 | 1.29 | $739,329 | $155,742 |
| 2014 | 369 | 1,482 | 73 | 1.29 | $607,404 | $115,857 |
| 2013 | 273 | 1,132 | 71 | 1.03 | $472,938 | $93,417 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 23 services
| Return visit (30+ min) | 442 | $70,986 | $111 |
| New patient visit (45+ min) | 214 | $29,186 | $136 |
| Diagnostic exam of bladder and urethra using an endoscope | 86 | $23,684 | $249 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 17 | $16,054 | None |
| Short return visit (20+ min) | 104 | $10,567 | $81 |
| Long return visit (40+ min) | 49 | $9,697 | $162 |
| Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope | 28 | $9,587 | $320 |
| Crushing of stone of ureter with insertion of stent using an endoscope | 23 | $9,343 | $374 |
| Ultrasound measurement of bladder capacity after voiding | 434 | $6,192 | $11 |
| Ultrasound scan of pelvic region through rectum | 47 | $5,837 | $124 |
| Biopsy of prostate gland | 23 | $5,661 | $246 |
| Dilation of urethra using an endoscope | 12 | $4,499 | $321 |
| Complicated insertion of bladder tube | 15 | $3,937 | $146 |
| Other ultrasound procedure | 14 | $3,635 | $260 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 18 | $1,224 | $36 |
| Telephone medical discussion with physician, 11-20 minutes | 16 | $1,036 | $65 |
| Telephone medical discussion with physician, 21-30 minutes | 11 | $1,018 | $93 |
| Imaging of urinary tract following injection of a contrast agent | 35 | $849 | $22 |
| Injection of drug or substance under skin or into muscle | 30 | $585 | $14 |
| Automated urinalysis test | 184 | $471 | $2 |
| Electronic assessment of bladder emptying | 35 | $335 | $9 |
| Manual urinalysis test with examination using microscope, automated | 36 | $124 | $3 |
| Injection, garamycin, gentamicin, up to 80 mg | 26 | $63 | None |
2022: 24 services
| Return visit (30+ min) | 465 | $75,348 | $112 |
| New patient visit (45+ min) | 169 | $23,402 | $138 |
| Diagnostic exam of bladder and urethra using an endoscope | 71 | $20,070 | $251 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 14 | $12,549 | None |
| Short return visit (20+ min) | 86 | $9,073 | $82 |
| Crushing of stone of ureter with insertion of stent using an endoscope | 22 | $8,093 | $311 |
| Long return visit (40+ min) | 43 | $7,676 | $157 |
| Ultrasound scan of pelvic region through rectum | 66 | $7,580 | $108 |
| Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope | 21 | $7,541 | $328 |
| Dilation of urethra using an endoscope | 13 | $6,007 | $334 |
| Biopsy of prostate gland | 22 | $5,247 | $238 |
| Insertion of lower leg neurostimulator electrode | 14 | $4,937 | $120 |
| Ultrasound measurement of bladder capacity after voiding | 349 | $4,715 | $10 |
| Telephone medical discussion with physician, 21-30 minutes | 21 | $2,024 | $92 |
| Telephone medical discussion with physician, 11-20 minutes | 18 | $1,234 | $69 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 35 | $868 | $21 |
| Imaging of urinary tract following injection of a contrast agent | 31 | $833 | $23 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 14 | $698 | $35 |
| Injection of drug or substance under skin or into muscle | 31 | $642 | $14 |
| 3d radiographic procedure with computerized image postprocessing | 12 | $429 | $36 |
| Automated urinalysis test | 157 | $413 | $2 |
| Electronic assessment of bladder emptying | 22 | $220 | $10 |
| Manual urinalysis test with examination using microscope, automated | 41 | $135 | $3 |
| Injection, garamycin, gentamicin, up to 80 mg | 24 | $39 | None |
2021: 29 services
| Return visit (30+ min) | 427 | $70,537 | $114 |
| New patient visit (45+ min) | 172 | $24,768 | $144 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 23 | $22,318 | None |
| Diagnostic exam of bladder and urethra using an endoscope | 72 | $19,528 | $244 |
| Removal of prostate gland using an electrocautery knife through urethra with control of bleeding using an endoscope | 22 | $14,783 | $672 |
| Crushing of stone of ureter with insertion of stent using an endoscope | 35 | $13,288 | $350 |
| Short return visit (20+ min) | 117 | $11,295 | $82 |
| Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope | 30 | $9,915 | $320 |
| Ultrasound scan of pelvic region through rectum | 79 | $8,716 | $109 |
| Biopsy of prostate gland | 30 | $7,747 | $258 |
| Long return visit (40+ min) | 37 | $7,653 | $166 |
| Dilation of urethra using an endoscope | 14 | $6,770 | $339 |
| Insertion of lower leg neurostimulator electrode | 15 | $5,083 | $130 |
| Ultrasound measurement of bladder capacity after voiding | 325 | $4,814 | $11 |
| Destruction of prostate tissue using radiofrequency induced heated water vapor | 14 | $4,761 | $340 |
| Complicated insertion of bladder tube | 14 | $4,218 | $141 |
| Telephone medical discussion with physician, 21-30 minutes | 24 | $2,337 | $87 |
| Telephone medical discussion with physician, 11-20 minutes | 22 | $1,589 | $66 |
| Removal or manipulation of stone in ureter or kidney using an endoscope | 13 | $1,467 | $105 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 23 | $1,265 | $34 |
| Imaging of urinary tract following injection of a contrast agent | 43 | $1,194 | $23 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 31 | $837 | $23 |
| 3d radiographic procedure with computerized image postprocessing | 23 | $833 | $36 |
| Injection of drug or substance under skin or into muscle | 44 | $808 | $14 |
| Short return visit | 11 | $553 | $50 |
| Automated urinalysis test | 204 | $540 | $2 |
| Electronic assessment of bladder emptying | 31 | $375 | $12 |
| Manual urinalysis test with examination using microscope, automated | 77 | $263 | $3 |
| Injection, garamycin, gentamicin, up to 80 mg | 37 | $64 | None |
2020: 23 services
| Return visit (30+ min) | 356 | $45,893 | $95 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 24 | $32,294 | None |
| New patient visit (45+ min) | 151 | $21,616 | $143 |
| Diagnostic exam of bladder and urethra using an endoscope | 67 | $15,740 | $213 |
| Crushing of stone of ureter with insertion of stent using an endoscope | 28 | $11,243 | $363 |
| Short return visit (20+ min) | 134 | $9,662 | $61 |
| Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope | 30 | $8,546 | $285 |
| Ultrasound scan of pelvic region through rectum | 58 | $7,781 | $132 |
| Dilation of urethra using an endoscope | 15 | $7,231 | $329 |
| Long return visit (40+ min) | 47 | $5,874 | $117 |
| Destruction of prostate tissue using radiofrequency induced heated water vapor | 15 | $5,379 | $359 |
| Biopsy of prostate gland | 20 | $5,097 | $255 |
| Telephone medical discussion with physician, 11-20 minutes | 47 | $3,400 | $64 |
| Ultrasound measurement of bladder capacity after voiding | 197 | $2,420 | $10 |
| Telephone medical discussion with physician, 21-30 minutes | 15 | $1,694 | $106 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 24 | $1,373 | $32 |
| Imaging of urinary tract following injection of a contrast agent | 41 | $1,059 | $24 |
| Injection of drug or substance under skin or into muscle | 42 | $735 | $13 |
| Short return visit | 16 | $678 | $40 |
| Automated urinalysis test | 156 | $459 | $2 |
| Online digital evaluation and management service for an established patient for up to 7 days, total time 5-10 minutes | 25 | $431 | $14 |
| Manual urinalysis test with examination using microscope, automated | 61 | $197 | $3 |
| Injection, garamycin, gentamicin, up to 80 mg | 33 | $51 | None |
2019: 27 services
| Return visit (30+ min) | 298 | $35,666 | $96 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 21 | $26,531 | None |
| New patient visit (45+ min) | 164 | $23,158 | $141 |
| Short return visit (20+ min) | 239 | $19,589 | $62 |
| Diagnostic exam of bladder and urethra using an endoscope | 65 | $13,737 | $181 |
| Insertion of lower leg neurostimulator electrode | 20 | $10,735 | $131 |
| Destruction of prostate tissue using radiofrequency induced heated water vapor | 29 | $10,110 | $349 |
| Ultrasound scan of pelvic region through rectum | 87 | $8,970 | $95 |
| Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope | 31 | $8,549 | $259 |
| Long return visit (40+ min) | 58 | $8,097 | $133 |
| Biopsy of prostate gland | 32 | $7,786 | $243 |
| Crushing of stone of ureter with insertion of stent using an endoscope | 21 | $7,743 | $352 |
| Dilation of urethra using an endoscope | 13 | $5,399 | $300 |
| Ultrasound measurement of bladder capacity after voiding | 273 | $4,867 | $13 |
| Complicated insertion of bladder tube | 13 | $2,831 | $123 |
| New patient visit (60+ min) | 14 | $2,629 | $188 |
| New patient visit (30+ min) | 20 | $1,910 | $95 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 20 | $1,150 | $31 |
| 3d radiographic procedure with computerized image postprocessing | 26 | $983 | $38 |
| Imaging of urinary tract following injection of a contrast agent | 31 | $897 | $24 |
| Automated urinalysis test | 222 | $759 | $2 |
| Injection of drug or substance under skin or into muscle | 37 | $731 | $16 |
| Short return visit | 13 | $574 | $41 |
| Ultrasonic guidance for needle placement | 15 | $437 | $29 |
| Manual urinalysis test with examination using microscope, automated | 84 | $310 | $3 |
| Electronic assessment of bladder emptying | 11 | $112 | $10 |
| Injection, garamycin, gentamicin, up to 80 mg | 29 | $43 | None |
2018: 26 services
| Destruction of prostate tissue using radiofrequency induced heat | 19 | $36,609 | $1,927 |
| Return visit (30+ min) | 242 | $30,800 | $93 |
| New patient visit (45+ min) | 148 | $21,028 | $142 |
| Short return visit (20+ min) | 210 | $16,788 | $62 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 11 | $16,285 | None |
| Diagnostic exam of bladder and urethra using an endoscope | 59 | $10,293 | $158 |
| Crushing of stone of ureter with insertion of stent using an endoscope | 22 | $8,284 | $331 |
| Removal of prostate gland using an electrocautery knife through urethra with control of bleeding using an endoscope | 12 | $7,550 | $629 |
| Ultrasound measurement of bladder capacity after voiding | 263 | $6,041 | $16 |
| Insertion of lower leg neurostimulator electrode | 15 | $5,723 | $127 |
| Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope | 24 | $5,603 | $233 |
| Long return visit (40+ min) | 34 | $4,659 | $129 |
| Biopsy of prostate gland | 20 | $4,634 | $232 |
| Ultrasound scan of pelvic region through rectum | 57 | $4,375 | $77 |
| Dilation of urethra using an endoscope | 13 | $4,037 | $269 |
| New patient visit (30+ min) | 24 | $2,267 | $94 |
| Simple bladder irrigation and/or instillation | 11 | $1,029 | $69 |
| Injection of drug or substance under skin or into muscle | 31 | $817 | $20 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 11 | $781 | $30 |
| Automated urinalysis test | 196 | $721 | $3 |
| Imaging of urinary tract following injection of a contrast agent | 29 | $623 | $16 |
| Ultrasonic guidance for needle placement | 14 | $549 | $39 |
| Manual urinalysis test with examination using microscope, automated | 107 | $463 | $4 |
| 3d radiographic procedure with computerized image postprocessing | 12 | $429 | $36 |
| Electronic assessment of bladder emptying | 21 | $335 | $13 |
| Injection, garamycin, gentamicin, up to 80 mg | 26 | $32 | None |
2017: 21 services
| Return visit (30+ min) | 174 | $22,212 | $92 |
| Short return visit (20+ min) | 202 | $17,914 | $61 |
| New patient visit (45+ min) | 128 | $17,228 | $135 |
| Diagnostic exam of bladder and urethra using an endoscope | 74 | $12,977 | $153 |
| Removal of prostate gland using an electrocautery knife through urethra with control of bleeding using an endoscope | 14 | $10,693 | $764 |
| Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope | 30 | $7,364 | $230 |
| Ultrasound measurement of bladder capacity after voiding | 221 | $6,217 | $19 |
| New patient visit (30+ min) | 62 | $5,958 | $96 |
| Crushing of stone of ureter with insertion of stent using an endoscope | 12 | $5,396 | $360 |
| Insertion of lower leg neurostimulator electrode | 13 | $3,905 | $118 |
| Long return visit (40+ min) | 28 | $3,863 | $125 |
| Dilation of urethra using an endoscope | 11 | $3,730 | $249 |
| Ultrasound scan of pelvic region through rectum | 38 | $3,630 | $91 |
| Simple bladder irrigation and/or instillation | 18 | $1,624 | $68 |
| Automated urinalysis test | 180 | $728 | $3 |
| Injection of drug or substance under skin or into muscle | 19 | $507 | $25 |
| Short return visit | 13 | $496 | $31 |
| Manual urinalysis test with examination using microscope, automated | 92 | $439 | $4 |
| Imaging of urinary tract following injection of a contrast agent | 21 | $412 | $16 |
| Electronic assessment of bladder emptying | 21 | $365 | $13 |
| Injection, garamycin, gentamicin, up to 80 mg | 11 | $16 | None |
2016: 19 services
| Short return visit (20+ min) | 197 | $16,122 | $58 |
| Return visit (30+ min) | 142 | $15,844 | $90 |
| Diagnostic exam of bladder and urethra using an endoscope | 64 | $14,575 | $182 |
| New patient visit (45+ min) | 100 | $13,387 | $134 |
| Crushing of stone of ureter with insertion of stent using an endoscope | 21 | $9,477 | $365 |
| Insertion of lower leg neurostimulator electrode | 21 | $8,150 | $127 |
| Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope | 22 | $6,711 | $224 |
| New patient visit (30+ min) | 58 | $5,070 | $87 |
| Ultrasound measurement of bladder capacity after voiding | 149 | $3,464 | $18 |
| Simple change of bladder tube | 12 | $3,193 | $76 |
| Complicated insertion of bladder tube | 11 | $2,833 | $118 |
| Ultrasound scan of pelvic region through rectum | 18 | $1,444 | $80 |
| Short return visit | 17 | $760 | $40 |
| Injection of drug or substance under skin or into muscle | 19 | $657 | $24 |
| Imaging of urinary tract following injection of a contrast agent | 26 | $575 | $16 |
| Automated urinalysis test | 136 | $522 | $3 |
| Manual urinalysis test with examination using microscope, automated | 74 | $348 | $4 |
| Electronic assessment of bladder emptying | 13 | $215 | $12 |
| Injection, garamycin, gentamicin, up to 80 mg | 11 | $18 | None |
2015: 20 services
| Short return visit (20+ min) | 176 | $18,926 | $63 |
| Diagnostic exam of bladder and urethra using an endoscope | 68 | $17,759 | $193 |
| Return visit (30+ min) | 119 | $15,344 | $95 |
| New patient visit (45+ min) | 75 | $11,249 | $150 |
| Crushing of stone of ureter with insertion of stent using an endoscope | 23 | $10,443 | $360 |
| Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope | 15 | $4,234 | $235 |
| New patient visit (30+ min) | 44 | $3,957 | $90 |
| Ultrasound measurement of bladder capacity after voiding | 120 | $2,947 | $19 |
| Insertion of lower leg neurostimulator electrode | 11 | $2,921 | $127 |
| Long return visit (40+ min) | 17 | $2,334 | $137 |
| Simple bladder irrigation and/or instillation | 11 | $1,126 | $70 |
| Ultrasound scan of pelvic region through rectum | 13 | $1,099 | $85 |
| Insertion of stent in ureter using an endoscope | 11 | $958 | $74 |
| Injection of drug or substance under skin or into muscle | 30 | $818 | $26 |
| Short return visit | 11 | $490 | $41 |
| Imaging of urinary tract following injection of a contrast agent | 21 | $429 | $17 |
| Manual urinalysis test with examination using microscope, automated | 75 | $390 | $4 |
| Automated urinalysis test | 93 | $372 | $3 |
| Urinalysis, manual test | 24 | $94 | $3 |
| Injection, garamycin, gentamicin, up to 80 mg | 22 | $25 | None |
2014: 21 services
| Short return visit (20+ min) | 175 | $15,662 | $61 |
| Diagnostic exam of bladder and urethra using an endoscope | 66 | $14,694 | $181 |
| New patient visit (45+ min) | 93 | $12,921 | $139 |
| Return visit (30+ min) | 93 | $10,013 | $92 |
| New patient visit (30+ min) | 68 | $6,140 | $90 |
| Crushing of stone of ureter with insertion of stent using an endoscope | 14 | $5,470 | $391 |
| Insertion of lower leg neurostimulator electrode | 14 | $3,963 | $110 |
| Biopsy of prostate gland | 15 | $2,643 | $176 |
| Ultrasound measurement of bladder capacity after voiding | 115 | $2,587 | $18 |
| Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope | 12 | $2,393 | $199 |
| Ultrasound scan of pelvic region through rectum | 22 | $1,947 | $88 |
| Insertion of stent in ureter using an endoscope | 12 | $1,249 | $89 |
| Ultrasonic guidance for needle placement | 16 | $1,104 | $65 |
| Short return visit (20+ min) | 28 | $1,001 | $32 |
| Injection of drug or substance under skin or into muscle | 26 | $756 | $24 |
| Short return visit | 19 | $753 | $33 |
| Imaging of urinary tract following injection of a contrast agent | 24 | $432 | $16 |
| Urinalysis, manual test | 96 | $363 | $3 |
| Manual urinalysis test with examination using microscope, automated | 61 | $311 | $4 |
| Automated urinalysis test | 35 | $114 | $3 |
| Injection, garamycin, gentamicin, up to 80 mg | 24 | $33 | None |
2013: 19 services
| Diagnostic exam of bladder and urethra using an endoscope | 50 | $10,392 | $182 |
| New patient visit (45+ min) | 65 | $9,170 | $141 |
| Short return visit (20+ min) | 87 | $8,499 | $64 |
| New patient visit (30+ min) | 88 | $8,102 | $92 |
| Return visit (30+ min) | 62 | $7,864 | $96 |
| Crushing of stone of ureter using an endoscope | 13 | $4,162 | $297 |
| Ultrasound measurement of bladder capacity after voiding | 109 | $2,652 | $20 |
| Complicated insertion of bladder tube | 15 | $2,492 | $119 |
| Short return visit (20+ min) | 23 | $1,342 | $43 |
| Insertion of stent in ureter using an endoscope | 16 | $1,152 | $61 |
| Ultrasound scan of pelvic region through rectum | 15 | $1,116 | $70 |
| Short return visit | 17 | $812 | $41 |
| Injection of drug or substance under skin or into muscle | 15 | $429 | $25 |
| Urinalysis, manual test | 74 | $329 | $3 |
| Imaging of urinary tract following injection of a contrast agent | 12 | $244 | $15 |
| Manual urinalysis test with examination using microscope, automated | 42 | $201 | $4 |
| Short return visit | 12 | $185 | $15 |
| Automated urinalysis test | 12 | $46 | $3 |
| Injection, garamycin, gentamicin, up to 80 mg | 17 | $19 | None |
Drugs they prescribed that Part D paid
$252,062
Pharmacies billed $252,062 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 1% of their Part D prescriptions (30 of 3,269) in 2024. At or below the middle of the specialty; the typical urology clinician is at 2%.
3,033 generic and fewer than 11 brand-name prescriptions · $252,062 in drug cost · 351 antibiotic prescriptions to 199 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Myrbetriq | 174 | $143,900 | $827 |
| Tamsulosin | 949 | $18,056 | $19 |
| Gemtesa | 24 | $17,852 | $744 |
| Finasteride | 821 | $12,344 | $15 |
| Potassium Citrate Er | 73 | $8,439 | $116 |
See all 33 drugs
| Myrbetriq | 174 | $143,900 | $827 |
| Tamsulosin | 949 | $18,056 | $19 |
| Gemtesa | 24 | $17,852 | $744 |
| Finasteride | 821 | $12,344 | $15 |
| Potassium Citrate Er | 73 | $8,439 | $116 |
| Estradiol | 80 | $5,481 | $69 |
| Solifenacin | 82 | $3,854 | $47 |
| Methenamine Hippurate | 40 | $3,497 | $87 |
| Oxybutynin Chloride Er | 92 | $3,193 | $35 |
| Tolterodine Tartrate Er | 15 | $2,959 | $197 |
| Renacidin | 12 | $2,235 | $186 |
| Trospium Chloride | 44 | $1,948 | $44 |
| Testosterone | 16 | $1,852 | $116 |
| Silodosin | 19 | $1,639 | $86 |
| Alfuzosin Hcl Er | 94 | $1,450 | $15 |
| Tadalafil | 29 | $1,284 | $44 |
| Dutasteride | 23 | $1,208 | $53 |
| Terazosin | 39 | $1,142 | $29 |
| Testosterone Cypionate | 14 | $1,033 | $74 |
| Nitrofurantoin | 19 | $795 | $42 |
| Cephalexin | 93 | $751 | $8 |
| Sulfamethoxazole-Trimethoprim | 95 | $523 | $6 |
| Chlorthalidone | 22 | $430 | $20 |
| Doxazosin Mesylate | 31 | $375 | $12 |
| Allopurinol | 14 | $289 | $21 |
| Ciprofloxacin | 69 | $191 | $3 |
| Nitrofurantoin Mono-Macro | 19 | $161 | $8 |
| Trazodone | 17 | $159 | $9 |
| Hydrocodone-Acetaminophen | 26 | $144 | $6 |
| Cefdinir | 13 | $129 | $10 |
| Fluconazole | 17 | $126 | $7 |
| Amoxicillin-Clavulanate Potass | 16 | $125 | $8 |
| Levofloxacin | 14 | $64 | $5 |
Year by year
| 2024 | 3,269 | 772 | 1% (30) | None | $252,062 |
| 2023 | 2,880 | 694 | 1% (32) | None | $267,378 |
| 2022 | 2,565 | 624 | 1% (34) | None | $188,036 |
| 2021 | 2,554 | 593 | 2% (45) | None | $205,969 |
| 2020 | 2,538 | 579 | 2% (49) | None | $220,920 |
| 2019 | 2,272 | 533 | 3% (64) | None | $193,621 |
| 2018 | 2,013 | 435 | 3% (68) | None | $162,590 |
| 2017 | 1,797 | 370 | 2% (40) | None | $126,033 |
| 2016 | 1,451 | 289 | 2% (26) | None | $108,966 |
| 2015 | 1,186 | 249 | 4% (48) | None | $86,030 |
| 2014 | 1,044 | 224 | 2% (19) | None | $80,163 |
| 2013 | 774 | 199 | 3% (22) | 25% | $54,995 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 36 drugs
| Myrbetriq | 203 | $161,293 | $795 |
| Tamsulosin | 769 | $20,230 | $26 |
| Solifenacin | 67 | $12,379 | $185 |
| Finasteride | 627 | $11,286 | $18 |
| Potassium Citrate Er | 61 | $8,972 | $147 |
| Estradiol | 51 | $6,128 | $120 |
| Oxybutynin Chloride Er | 139 | $5,259 | $38 |
| Methenamine Hippurate | 36 | $4,502 | $125 |
| Renacidin | 15 | $3,045 | $203 |
| Alfuzosin Hcl Er | 62 | $2,639 | $43 |
| Terazosin | 48 | $2,102 | $44 |
| Tolterodine Tartrate Er | 18 | $1,770 | $98 |
| Silodosin | 12 | $1,749 | $146 |
| Trospium Chloride | 20 | $1,438 | $72 |
| Dutasteride | 22 | $1,293 | $59 |
| Cephalexin | 82 | $1,179 | $14 |
| Nitrofurantoin | 18 | $866 | $48 |
| Doxazosin Mesylate | 29 | $852 | $29 |
| Tadalafil | 36 | $710 | $20 |
| Sulfamethoxazole-Trimethoprim | 82 | $557 | $7 |
| Bicalutamide | 12 | $522 | $43 |
| Oxybutynin Chloride | 20 | $444 | $22 |
| Chlorthalidone | 22 | $408 | $19 |
| Cefdinir | 21 | $393 | $19 |
| Nitrofurantoin Mono-Macro | 18 | $358 | $20 |
| Potassium Chloride | 13 | $314 | $24 |
| Ciprofloxacin | 74 | $274 | $4 |
| Clotrimazole-Betamethasone | 12 | $267 | $22 |
| Allopurinol | 16 | $266 | $17 |
| Lactulose | 14 | $215 | $15 |
| Trazodone | 21 | $188 | $9 |
| Amitriptyline | 16 | $161 | $10 |
| Amoxicillin-Clavulanate Potass | 12 | $118 | $10 |
| Levofloxacin | 17 | $107 | $6 |
| Hydrocodone-Acetaminophen | 26 | $84 | $3 |
| Amoxicillin | 12 | $57 | $5 |
2022: 29 drugs
| Myrbetriq | 125 | $93,743 | $750 |
| Tamsulosin | 705 | $15,772 | $22 |
| Finasteride | 618 | $12,373 | $20 |
| Potassium Citrate Er | 58 | $7,729 | $133 |
| Solifenacin | 45 | $5,343 | $119 |
| Oxybutynin Chloride Er | 109 | $5,313 | $49 |
| Estradiol | 37 | $4,066 | $110 |
| Methenamine Hippurate | 29 | $3,887 | $134 |
| Tolterodine Tartrate Er | 29 | $2,931 | $101 |
| Renacidin | 12 | $2,215 | $185 |
| Alfuzosin Hcl Er | 52 | $1,926 | $37 |
| Silodosin | 15 | $1,798 | $120 |
| Terazosin | 29 | $1,751 | $60 |
| Nitrofurantoin | 18 | $1,620 | $90 |
| Trospium Chloride | 16 | $965 | $60 |
| Oxybutynin Chloride | 31 | $948 | $31 |
| Cephalexin | 84 | $781 | $9 |
| Tadalafil | 26 | $757 | $29 |
| Sulfamethoxazole-Trimethoprim | 68 | $463 | $7 |
| Doxazosin Mesylate | 27 | $439 | $16 |
| Allopurinol | 23 | $386 | $17 |
| Ciprofloxacin | 77 | $348 | $5 |
| Trazodone | 38 | $304 | $8 |
| Nitrofurantoin Mono-Macro | 17 | $208 | $12 |
| Amitriptyline | 16 | $190 | $12 |
| Cefdinir | 13 | $129 | $10 |
| Amoxicillin-Clavulanate Potass | 14 | $125 | $9 |
| Amoxicillin | 16 | $108 | $7 |
| Hydrocodone-Acetaminophen | 30 | $101 | $3 |
2021: 31 drugs
| Myrbetriq | 155 | $108,281 | $699 |
| Tamsulosin | 720 | $16,293 | $23 |
| Finasteride | 582 | $14,633 | $25 |
| Premarin | 15 | $6,456 | $430 |
| Potassium Citrate Er | 48 | $5,900 | $123 |
| Oxybutynin Chloride Er | 98 | $4,953 | $51 |
| Methenamine Hippurate | 29 | $4,817 | $166 |
| Estradiol | 30 | $3,518 | $117 |
| Tolterodine Tartrate Er | 16 | $3,077 | $192 |
| Solifenacin | 33 | $3,015 | $91 |
| Alfuzosin Hcl Er | 59 | $2,819 | $48 |
| Renacidin | 11 | $2,030 | $185 |
| Terazosin | 38 | $1,780 | $47 |
| Trospium Chloride | 32 | $1,510 | $47 |
| Dutasteride | 14 | $1,300 | $93 |
| Silodosin | 13 | $1,106 | $85 |
| Nitrofurantoin | 14 | $954 | $68 |
| Cephalexin | 98 | $896 | $9 |
| Oxybutynin Chloride | 38 | $833 | $22 |
| Tadalafil | 30 | $652 | $22 |
| Doxazosin Mesylate | 31 | $624 | $20 |
| Allopurinol | 32 | $543 | $17 |
| Sulfamethoxazole-Trimethoprim | 48 | $352 | $7 |
| Bicalutamide | 11 | $336 | $31 |
| Nitrofurantoin Mono-Macro | 14 | $264 | $19 |
| Ciprofloxacin | 89 | $260 | $3 |
| Amitriptyline | 16 | $161 | $10 |
| Hydrocodone-Acetaminophen | 36 | $159 | $4 |
| Amoxicillin-Clavulanate Potass | 12 | $131 | $11 |
| Pantoprazole | 12 | $125 | $10 |
| Amoxicillin | 12 | $66 | $5 |
2020: 32 drugs
| Myrbetriq | 190 | $118,450 | $623 |
| Tamsulosin | 723 | $15,783 | $22 |
| Finasteride | 557 | $12,800 | $23 |
| Toviaz | 14 | $7,268 | $519 |
| Potassium Citrate Er | 42 | $7,199 | $171 |
| Premarin | 15 | $5,982 | $399 |
| Oxybutynin Chloride Er | 101 | $5,960 | $59 |
| Methenamine Hippurate | 32 | $5,232 | $163 |
| Monurol | 12 | $3,796 | $316 |
| Estradiol | 19 | $3,694 | $194 |
| Tolterodine Tartrate Er | 13 | $2,843 | $219 |
| Solifenacin | 36 | $2,517 | $70 |
| Renacidin | 12 | $2,215 | $185 |
| Dutasteride | 16 | $1,305 | $82 |
| Cephalexin | 134 | $1,213 | $9 |
| Alfuzosin Hcl Er | 35 | $1,157 | $33 |
| Tadalafil | 16 | $1,126 | $70 |
| Doxazosin Mesylate | 23 | $1,013 | $44 |
| Terazosin | 21 | $754 | $36 |
| Oxybutynin Chloride | 32 | $722 | $23 |
| Desmopressin Acetate | 11 | $625 | $57 |
| Nitrofurantoin Mono-Macro | 24 | $614 | $26 |
| Bicalutamide | 15 | $493 | $33 |
| Cefdinir | 15 | $395 | $26 |
| Sulfamethoxazole-Trimethoprim | 65 | $389 | $6 |
| Ciprofloxacin | 85 | $310 | $4 |
| Amoxicillin-Clavulanate Potass | 20 | $212 | $11 |
| Hydrocodone-Acetaminophen | 37 | $181 | $5 |
| Amitriptyline | 18 | $164 | $9 |
| Allopurinol | 12 | $141 | $12 |
| Fluconazole | 14 | $119 | $8 |
| Amoxicillin | 12 | $55 | $5 |
2019: 25 drugs
| Myrbetriq | 139 | $85,214 | $613 |
| Finasteride | 484 | $13,092 | $27 |
| Tamsulosin | 594 | $12,955 | $22 |
| Premarin | 25 | $9,359 | $374 |
| Potassium Citrate Er | 48 | $9,214 | $192 |
| Oxybutynin Chloride Er | 152 | $8,677 | $57 |
| Solifenacin | 19 | $6,026 | $317 |
| Methenamine Hippurate | 39 | $5,095 | $131 |
| Estradiol | 13 | $2,032 | $156 |
| Renacidin | 11 | $1,899 | $173 |
| Tolterodine Tartrate Er | 13 | $1,888 | $145 |
| Alfuzosin Hcl Er | 42 | $1,487 | $35 |
| Cephalexin | 130 | $1,264 | $10 |
| Dutasteride | 16 | $1,079 | $67 |
| Doxazosin Mesylate | 24 | $905 | $38 |
| Terazosin | 20 | $734 | $37 |
| Sulfamethoxazole-Trimethoprim | 82 | $535 | $7 |
| Oxybutynin Chloride | 40 | $502 | $13 |
| Ciprofloxacin | 99 | $495 | $5 |
| Nitrofurantoin Mono-Macro | 22 | $391 | $18 |
| Bicalutamide | 13 | $370 | $28 |
| Cefdinir | 11 | $260 | $24 |
| Amoxicillin-Clavulanate Potass | 22 | $251 | $11 |
| Hydrocodone-Acetaminophen | 48 | $215 | $4 |
| Fluconazole | 12 | $183 | $15 |
2018: 26 drugs
| Myrbetriq | 73 | $43,860 | $601 |
| Tamsulosin | 552 | $13,734 | $25 |
| Finasteride | 408 | $8,715 | $21 |
| Premarin | 22 | $7,992 | $363 |
| Oxybutynin Chloride Er | 146 | $7,398 | $51 |
| Potassium Citrate Er | 32 | $6,737 | $211 |
| Methenamine Hippurate | 49 | $5,935 | $121 |
| Cialis | 12 | $5,916 | $493 |
| Renacidin | 12 | $2,050 | $171 |
| Doxazosin Mesylate | 17 | $1,256 | $74 |
| Polyethylene Glycol 3350 | 25 | $1,063 | $43 |
| Cephalexin | 105 | $1,006 | $10 |
| Dutasteride | 11 | $739 | $67 |
| Nitrofurantoin Mono-Macro | 21 | $736 | $35 |
| Alfuzosin Hcl Er | 25 | $632 | $25 |
| Oxybutynin Chloride | 50 | $572 | $11 |
| Bicalutamide | 11 | $558 | $51 |
| Nitrofurantoin | 18 | $534 | $30 |
| Ciprofloxacin | 80 | $429 | $5 |
| Terazosin | 14 | $403 | $29 |
| Sulfamethoxazole-Trimethoprim | 59 | $393 | $7 |
| Hydrocodone-Acetaminophen | 59 | $350 | $6 |
| Amitriptyline | 17 | $307 | $18 |
| Levofloxacin | 11 | $95 | $9 |
| Amoxicillin | 13 | $83 | $6 |
| Diazepam | 15 | $14 | $1 |
2017: 31 drugs
| Myrbetriq | 76 | $34,951 | $460 |
| Tamsulosin | 521 | $13,588 | $26 |
| Vesicare | 17 | $11,463 | $674 |
| Potassium Citrate Er | 27 | $9,568 | $354 |
| Cialis | 21 | $6,901 | $329 |
| Premarin | 19 | $6,569 | $346 |
| Finasteride | 334 | $6,454 | $19 |
| Oxybutynin Chloride Er | 132 | $6,151 | $47 |
| Monurol | 17 | $4,273 | $251 |
| Methenamine Hippurate | 24 | $3,953 | $165 |
| Vagifem | 13 | $3,667 | $282 |
| Rapaflo | 16 | $3,490 | $218 |
| Polyethylene Glycol 3350 | 19 | $1,014 | $53 |
| Doxazosin Mesylate | 17 | $931 | $55 |
| Alfuzosin Hcl Er | 28 | $844 | $30 |
| Nitrofurantoin Mono-Macro | 23 | $762 | $33 |
| Sulfamethoxazole-Trimethoprim | 91 | $614 | $7 |
| Econazole Nitrate | 11 | $611 | $56 |
| Cephalexin | 65 | $440 | $7 |
| Bicalutamide | 20 | $416 | $21 |
| Nitrofurantoin | 13 | $402 | $31 |
| Amitriptyline | 20 | $305 | $15 |
| Oxybutynin Chloride | 23 | $291 | $13 |
| Ciprofloxacin | 41 | $246 | $6 |
| Levofloxacin | 19 | $233 | $12 |
| Terazosin | 14 | $207 | $15 |
| Allopurinol | 11 | $174 | $16 |
| Hydrocodone-Acetaminophen | 30 | $172 | $6 |
| Fluconazole | 15 | $143 | $10 |
| Trazodone | 13 | $38 | $3 |
| Hydrochlorothiazide | 13 | $17 | $1 |
2016: 24 drugs
| Myrbetriq | 77 | $32,388 | $421 |
| Tamsulosin | 397 | $12,002 | $30 |
| Potassium Citrate Er | 41 | $10,760 | $262 |
| Premarin | 28 | $8,700 | $311 |
| Vesicare | 24 | $7,753 | $323 |
| Finasteride | 264 | $5,428 | $21 |
| Cialis | 13 | $4,744 | $365 |
| Vagifem | 15 | $3,907 | $260 |
| Oxybutynin Chloride Er | 101 | $3,481 | $34 |
| Methenamine Hippurate | 26 | $2,816 | $108 |
| Polyethylene Glycol 3350 | 16 | $943 | $59 |
| Doxazosin Mesylate | 17 | $599 | $35 |
| Sulfamethoxazole-Trimethoprim | 53 | $444 | $8 |
| Cephalexin | 58 | $437 | $8 |
| Bicalutamide | 13 | $426 | $33 |
| Alfuzosin Hcl Er | 14 | $419 | $30 |
| Levofloxacin | 32 | $387 | $12 |
| Ciprofloxacin | 44 | $288 | $7 |
| Terazosin | 15 | $259 | $17 |
| Allopurinol | 18 | $244 | $14 |
| Fluconazole | 17 | $161 | $9 |
| Hydrocodone-Acetaminophen | 17 | $159 | $9 |
| Amitriptyline | 15 | $76 | $5 |
| Hydrochlorothiazide | 13 | $16 | $1 |
2015: 21 drugs
| Myrbetriq | 84 | $27,022 | $322 |
| Potassium Citrate Er | 57 | $13,705 | $240 |
| Tamsulosin | 296 | $9,465 | $32 |
| Vesicare | 19 | $6,040 | $318 |
| Tolterodine Tartrate Er | 16 | $3,761 | $235 |
| Finasteride | 226 | $3,741 | $17 |
| Premarin | 14 | $3,462 | $247 |
| Oxybutynin Chloride Er | 49 | $1,909 | $39 |
| Doxazosin Mesylate | 20 | $777 | $39 |
| Chlorthalidone | 11 | $730 | $66 |
| Oxybutynin Chloride | 21 | $673 | $32 |
| Hydrocodone-Acetaminophen | 40 | $649 | $16 |
| Alfuzosin Hcl Er | 16 | $455 | $28 |
| Sulfamethoxazole-Trimethoprim | 45 | $400 | $9 |
| Levofloxacin | 26 | $352 | $14 |
| Allopurinol | 13 | $323 | $25 |
| Fluconazole | 23 | $234 | $10 |
| Cephalexin | 36 | $215 | $6 |
| Ciprofloxacin | 42 | $210 | $5 |
| Terazosin | 12 | $183 | $15 |
| Amitriptyline | 14 | $87 | $6 |
2014: 21 drugs
| Potassium Citrate Er | 69 | $17,397 | $252 |
| Vesicare | 35 | $10,345 | $296 |
| Myrbetriq | 41 | $10,311 | $251 |
| Premarin | 39 | $8,326 | $213 |
| Tamsulosin | 226 | $5,555 | $25 |
| Oxybutynin Chloride Er | 76 | $4,864 | $64 |
| Avodart | 22 | $3,768 | $171 |
| Finasteride | 158 | $2,326 | $15 |
| Oxybutynin Chloride | 39 | $1,406 | $36 |
| Bicalutamide | 20 | $1,404 | $70 |
| Doxazosin Mesylate | 17 | $774 | $46 |
| Nitrofurantoin | 14 | $673 | $48 |
| Alfuzosin Hcl Er | 19 | $645 | $34 |
| Chlorthalidone | 12 | $423 | $35 |
| Sulfamethoxazole-Trimethoprim | 21 | $230 | $11 |
| Cephalexin | 27 | $225 | $8 |
| Terazosin | 11 | $208 | $19 |
| Allopurinol | 15 | $178 | $12 |
| Ciprofloxacin | 38 | $176 | $5 |
| Hydrocodone-Acetaminophen | 17 | $149 | $9 |
| Levofloxacin | 13 | $97 | $7 |
2013: 16 drugs
| Potassium Citrate | 68 | $10,977 | $161 |
| Avodart | 31 | $10,276 | $331 |
| Vesicare | 30 | $7,441 | $248 |
| Tamsulosin | 190 | $4,987 | $26 |
| Oxybutynin Chloride Er | 39 | $4,200 | $108 |
| Premarin | 17 | $3,208 | $189 |
| Finasteride | 100 | $3,013 | $30 |
| Oxybutynin Chloride | 36 | $1,291 | $36 |
| Chlorthalidone | 19 | $445 | $23 |
| Doxazosin Mesylate | 22 | $355 | $16 |
| Polyethylene Glycol 3350 | 13 | $289 | $22 |
| Allopurinol | 28 | $195 | $7 |
| Sulfamethoxazole-Trimethoprim | 19 | $148 | $8 |
| Ciprofloxacin | 25 | $134 | $5 |
| Hydrocodone-Acetaminophen | 17 | $134 | $8 |
| Cephalexin | 11 | $72 | $7 |
Money from drug and device companies
$11,918 in 2025
| 2025 | 6 | 26 | $11,175 | $11,918 |
| 2024 | 5 | 34 | $16,400 | $19,392 |
| 2023 | 4 | 16 | $12,200 | $12,948 |
| 2022 | 3 | 11 | $8,100 | $8,353 |
| 2021 | 3 | 3 | None | $276 |
| 2020 | 3 | 4 | $3,150 | $3,292 |
| 2019 | 3 | 6 | $1,925 | $2,049 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Teleflex | Urolift | $11,175 | 13 payments
|
| Ferring Pharmaceuticals | Adstiladrin | $324 | 8 payments
|
| Boston Scientific | Spaceoar Vue System - 10ml | $159 | 1 payment
|
| Procept Biorobotics | Aquabeam Robotic System | $149 | 1 payment
|
| Abbvie | Botox | $61 | 2 payments
|
| Ambu | None | $50 | 1 payment
|
See all 26 published payments
| Abbvie | Meals · 2025-12-24 | Botox | $30 |
| Teleflex | Consulting · 2025-11-28 | Urolift | $275 |
| Ferring Pharmaceuticals | Meals · 2025-11-24 | Adstiladrin | $31 |
| Teleflex | Consulting · 2025-10-17 | Urolift | $1,100 |
| Abbvie | Meals · 2025-10-15 | Botox | $31 |
| Ferring Pharmaceuticals | Meals · 2025-09-29 | Adstiladrin | $36 |
| Ferring Pharmaceuticals | Meals · 2025-08-18 | Adstiladrin | $23 |
| Teleflex | Consulting · 2025-08-08 | Urolift | $100 |
| Teleflex | Consulting · 2025-07-03 | Urolift | $500 |
| Ferring Pharmaceuticals | Meals · 2025-06-16 | Adstiladrin | $25 |
| Teleflex | Consulting · 2025-06-13 | Urolift | $200 |
| Teleflex | Consulting · 2025-05-09 | Urolift | $400 |
| Procept Biorobotics | Meals · 2025-04-26 | Aquabeam Robotic System | $149 |
| Teleflex | Consulting · 2025-04-25 | Urolift | $2,200 |
| Ferring Pharmaceuticals | Meals · 2025-04-23 | Adstiladrin | $116 |
| Teleflex | Consulting · 2025-04-11 | Urolift | $2,400 |
| Teleflex | Consulting · 2025-04-11 | Urolift | $1,100 |
| Teleflex | Consulting · 2025-04-11 | Urolift | $800 |
| Ferring Pharmaceuticals | Meals · 2025-03-31 | Adstiladrin | $26 |
| Ferring Pharmaceuticals | Meals · 2025-03-13 | Adstiladrin | $40 |
| Boston Scientific | Meals · 2025-02-26 | Spaceoar Vue System - 10ml | $159 |
| Teleflex | Consulting · 2025-02-14 | Urolift | $600 |
| Teleflex | Consulting · 2025-02-14 | Urolift | $300 |
| Teleflex | Consulting · 2025-02-14 | Urolift | $1,200 |
| Ferring Pharmaceuticals | Meals · 2025-02-06 | Adstiladrin | $27 |
| Ambu | Meals · 2025-02-05 | None | $50 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $19,392
| Teleflex | Urolift | $18,240 | 25 payments
|
| Edap Technomed | None | $957 | 6 payments
|
| C. R. Bard Inc. & Subsidiaries | Bard Urinary Drainage Bag | $160 | 1 payment
|
| Coloplast | None | $18 | 1 payment
|
| Bluewind Medical | Revi | $17 | 1 payment
|
2023: $12,948
| Teleflex | Urolift | $12,200 | 7 payments
|
| Valencia Technologies | Ecoin Device Kit | $572 | 3 payments
|
| Boston Scientific | Spaceoar Vue System - 10ml | $126 | 4 payments
|
| Sumitomo Pharma America | Gemtesa | $50 | 2 payments
|
2022: $8,353
| Teleflex | Urolift System | $8,100 | 9 payments
|
| PROCEPT BioRobotics | Aquabeam Robotic System | $153 | 1 payment
|
| Dornier MedTech America | Dornier Medtech | $100 | 1 payment
|
2021: $276
| Dornier MedTech America | Consumables & Accessories | $224 | 1 payment
|
| Boston Scientific | Spaceoar Vue | $34 | 1 payment
|
| Astellas Pharma US | Xtandi | $19 | 1 payment
|
2020: $3,292
| NeoTract | Urolift | $3,150 | 1 payment
|
| Pfizer | Xtandi | $130 | 2 payments
|
| 180 Medical | Gentlecath | $12 | 1 payment
|
2019: $2,049
| NeoTract | Urolift | $1,925 | 3 payments
|
| Astellas Pharma US | None | $90 | 1 payment
|
| Pfizer | Toviaz | $34 | 2 payments
|
Research money
Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.
| NeoTract Inc. · Pulsar · 2020 | This clinician | $280 |
Professional record
- NPI
- 1225133788
- Licence
- CA A63122California A63122: Current · expires 2028-09-30
- Trained
- Stanford University School of Medicine, 1996
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Medicaid ID
- CA 00A631220
- Taxonomy
- Urology (208800000X)
- Mailing address
- 325 Distel Cir, Los Altos, CA, 94022
- NPI first listed
- 2006-09-13
- NPI last updated
- 2024-04-30
- NPI record certified
- 2024-04-30
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 3200 Kearney St, Fremont, CA, 94538